Corteva Inc SEC Filings

Corteva, Inc. reported Q3 2025 results with net sales of $2,618 million, up from $2,326 million a year ago. The quarter posted a net loss attributable to Corteva of $320 million and diluted EPS of $-0.47 versus $-0.76 last year, as higher sales were offset by costs and foreign exchange impacts.

Year-to-date, net sales reached $13,491 million and diluted EPS were $2.41 compared to $1.35 in 2024. Operating cash flow was $(969) million, improving from $(2,028) million last year. Cash and cash equivalents were $2,509 million, short‑term borrowings $2,685 million, and long‑term debt $1,688 million at September 30, 2025.

Segments: Seed Q3 sales were $917 million (driven by corn at $586 million), and Crop Protection was $1,701 million. The company continues its Crop Protection Operations Strategy Restructuring Program, expecting $650–$700 million in aggregate pre‑tax charges; $594 million has been recorded inception‑to‑date, with actions expected to be substantially complete by the end of 2026.

Corteva, Inc. (CTVA) furnished its quarterly results update. On November 4, 2025, the company announced consolidated financial results for the quarter ended September 30, 2025 and furnished the materials on a Form 8-K under Item 2.02.

The update includes a press release and financial statement schedules as Exhibits 99.1 and 99.2. The company states these materials are being furnished, not filed, under the Exchange Act. Corteva’s common stock trades on the NYSE under the symbol CTVA.

Corteva, Inc. (CTVA) director reported acquiring 528.9714 units of common stock on 10/31/2025 at $61.44 per share. The filing states these represent stock units acquired under the Issuer's Stock Accumulation and Deferred Compensation Plan for Directors, which are settled on a one-for-one basis in CTVA common stock on a future date selected at the time of the deferral election. Cash compensation deferred into stock units is calculated using the closing price on the date the cash compensation would have been payable.

Following the reported transaction, the director beneficially owns 32,890.9739 shares, held directly. This total includes the acquisition of 82.9204 shares pursuant to dividend reinvestment.

Corteva (CTVA) disclosed a director acquisition on a Form 4. On 10/31/2025, the director acquired 63.0697 stock units at $61.44 under the company’s Stock Accumulation and Deferred Compensation Plan for Directors, which settles one-for-one in CTVA common stock on a future date elected at deferral.

After the transaction, the director beneficially owned 17,464.8998 shares directly. The holdings include 43.4154 shares credited via dividend reinvestment.

Insider transaction summary for Corteva, Inc. (CTVA): On 09/16/2025 David Paul Johnson, Executive Vice President and Chief Financial Officer, had 6,754 shares of Corteva common stock disposed of at a price of $69.88 per share. The filing states the shares were withheld by the issuer to satisfy taxes due upon vesting of previously granted restricted stock units, not an open-market sale. After the transaction the reporting person beneficially owned 58,312.2466 shares, which includes 493.1945 shares acquired through dividend reinvestment.

Insider grants to Corteva SVP and Chief Legal Officer Jennifer Amy Johnson — The Form 4 discloses that on 09/15/2025 Ms. Johnson was granted 4,282 restricted stock units (RSUs) and a non-qualified stock option for 12,418 shares with an exercise price of $70.07. The RSUs vest in three equal annual installments beginning on the grant date and the option likewise vests in three equal annual installments; the option expires on 09/15/2035. Following the transactions, Ms. Johnson directly beneficially owns 4,282 common shares and holds options covering 12,418 shares. The Form 4 was signed under power of attorney on 09/17/2025.

Jennifer Amy Johnson, identified as Senior Vice President and Chief Legal Officer of Corteva, Inc. (CTVA), filed an Initial Statement of Beneficial Ownership reporting the event dated 09/15/2025. The filing indicates no securities are beneficially owned by the reporting person. The Form 3 was signed by an attorney-in-fact, Abigail Jarrell, on behalf of the reporting person on 09/17/2025.

Robert D. King, EVP, Crop Protection Business at Corteva, reported multiple equity transactions on 08/29/2025. He exercised 14,960 non-qualified options with an exercise price of $58.67 and 9,337 options at $62.29, receiving the same number of common shares. On the same date he sold 37,280 shares at a weighted average price of $74.1951, with sale prices ranging $74.17–$74.23. Following these transactions his reported beneficial ownership is 49,262.2876 shares (direct). The filing notes inclusion of 25.3808 shares from dividend reinvestment and provides option vesting/expiration details for the reported grants.